Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 5
Submit an article Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The signalling of AT2 and the influence on the collagen metabolism of AT2 receptor in adult rat cardiac fibroblasts

Xiao-Ying JiangDepartment of Physiology and Pathophysiology, College of Medicine, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China.
,
Guang-Dao GaoDepartment of Physiology and Pathophysiology, College of Medicine, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China.Correspondence[email protected]
,
Xiao-Jun DuBaker Heart Research Institute, Melbourne, Victoria 8008, Australia.
,
Juan ZhouDepartment of Physiology and Pathophysiology, College of Medicine, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China.
,
Xin-Feng WangDepartment of Physiology and Pathophysiology, College of Medicine, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China.
&
Yuan-Xi LinDepartment of Physiology and Pathophysiology, College of Medicine, Xi’an Jiaotong University, Xi’an, 710061, Shaanxi, China.
Pages 429-438 | Received 27 Feb 2007, Accepted 24 Aug 2007, Published online: 23 May 2017

References

  • Varagic J, Frohlich ED. Local cardiac renin-angiotensin system: Hypertension and cardiac failure. J Mol Cell Car-diol 2002; 34: 1435–42.
  • Dubey RK, Gillespie DG, Mi Z, Jackson EK. Exogenous and endogenous adenosine inhibits fetal calf serum-induced growth of rat cardiac fibroblasts: Role of A2B receptors. Circulation 1997; 96: 2656–66.
  • Lijnen PJ, Petrov VV. Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling. Meth-ods Find Exp Clin Pharmacol 2003; 25: 541–64.
  • Seeland U, Haeuseler C, Hinriches R, Rosenkranz S, Pfitzner T, Scharffetter-Kochanek K, Bohm M. Myocardial fibrosis in transforming growth factor-f31 (TGF-f31) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest 2002; 32: 295–303.
  • Sarkar S, Vellaichamy E, Young D, Sen S. Influence of cytokines and growth factors in Ang II-mediated collagen upregulation by fibroblasts in rats: role of myocytes. Am J Physiol Heart Circ Physiol 2004; 287: H107–17.
  • Steckelings UM, Kaschina E, Unger T. The AT2 receptor - A matter of love and hate. Peptides 2005; 26: 1401–9.
  • Gross V, Obst M, Luft FC. Insights into angiotensin II receptor function through AT2 receptor knockout mice. Acta Physiol Scand 2004; 181: 487–94.
  • Zhu YC, Zhu YZ, Lu N, Wang MJ, Wang YX and Yao T. Role of angiotensin AT1 and AT2 receptors in cardiac hyper-trophy and cardiac remodeling. Clin Exp Pharmacol Phys-iol 2003; 30: 911–8.
  • Oishi Y, Ozono R, Yano Y, Teranishi Y, Akishita M, Hori-uchi M, Oshima T, Kambe M. Cardioprotective role of AT2 receptor in postinfarctong left ventricular remodeling. Hypertension 2003; 41: 814–8.
  • Kurisu S, Ozono R, Oshima T, Kambe M, Ishida T, Sugino H, Matsuura H, Chayama K, Teranishi Y, Iba O, Amano K, Matsubara H. Cardiac angiotensin II type 2 receptor acti-vates the kinin/NO system and inhibits fibrosis. Hypertension 2003; 41: 99–107.
  • Jones ES, Black MJ, Widdop RE. Angiotensin AT2 recep-tor contributes to cardiovascular remodelling of aged SHR during chronic AT1 receptor blockade. J Mol Cell Cardiol 2004; 37: 1023–30.
  • D’Amore A, Black MJ, Thomas WG. The AT2 receptor causes constitutive growth of cardiomyocytes and does not antagonize AT1 receptor-mediated hypertrophy. Hyperten-sion 2005; 46: 1347–54.
  • Berk BC. Angiotensin II receptors and angiotensin II-stim-ulated signal transduction. Heart Failure Reviews 1998; 3: 87–99.
  • Csikos T, Chung O, Unger T. Role of angiotensin II in hyper-tension-induced cardiac hypertrophy and failure. Heart Fail-ure Reviews 1999; 3: 159–68.
  • Hou M, Pantev E, Moller S, Erlinge D, Edvinsson L. Angiotensin II type 1 receptors stimulate protein synthesis in human cardiac fibroblasts via a Ca2 +-sensitive PKC-dependent tyrosine kinase pathway. Acta Physiol Scand 2000; 168: 301–9.
  • Abbasi S, Su B, Kellems RE, Yang J, Xia Y. The essential role of MEKK3 signaling in angiotensin II-induced cal-cineurin/nuclear factor of activated T-cells activation. J Biol Chem 2005; 280: 36737–46.
  • Pulakat L, Rahman S, Gray A, Knowle D, Gavini N. Roles of the intracellular regions of angiotensin II receptor AT2 in mediating reduction of intracellular cGMP levels. Cell Signal 2005; 17: 395–404.
  • Ritter 0, Schuh K, Brede M, Rothlein N, Burkard N, Hein L, Neyses L. AT2 receptor activation regulates myocardial eNOS expression via the calcineurin-NF-AT pathway. FASEB J2002; 16: 283–5.
  • Andresen BT, Shome K, Jackson EK, Romero GG. AT2 receptors cross-talk with AT1 receptors through a nitric oxide and RhoA dependent mechanism resulting in decreased phospholipase D activity. Am J Physiol Renal Physiol 2005; 288: F763–70.
  • Fritz RD, Radziwill G. The scaffold protein CNK1 inter-acts with the angiotensin II type 2 receptor. Biochem Biophys Res Commun 2005; 338: 1906–12.
  • Kumar D, Menon V, Ford WR, Clanachan AS, Jugdutt BI. Effect of angiotensin II type 2 receptor blockade on mito-gen activated protein kinases during myocardial ischemia-reperfusion. Mol Cell Bio 2004; 258: 211–8.
  • Seta K, Sadoshima J. Phosphorylation of tyrosine 319 of the angiotensin II type 1 receptor mediates angiotensin II-induced trans-activation of the epidermal growth factor receptor. J Biol Chem 2003; 278: 9019–26.
  • Nouet S, Amzallag N, Li JM, Louis S, Seitz I, Cui TX, Alleaume AM, Di Benedetto M, Boden C, Masson M, Stros-berg AD, Horiuchi M, Couraud PO, Nahmias C. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004; 279: 28989–97.
  • Chen K, Chen SW, Li DY, Zhang XJ, Mehta JL. Angiotensin II regulation of collagen type I expression in cardiac fibrob-lasts-modulation by PPAR-gamma ligand pioglitazone. Hypertension 2004; 44: 655–61.
  • Lijnen PJ, Petrov VV, Fagard RH. Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. J Renin Angiotensin Aldosterone Syst 2001; 2: 117–22.
  • Diez J. Emerging role of matrix metalloproteinases in the pathophysiology of cardiac diseases. Eur J Clin Invest 2002; 32: 291–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.